Detalhe da pesquisa
1.
Bromodomain inhibitors a decade later: a promise unfulfilled?
Br J Cancer
; 123(12): 1713-1714, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32989227
2.
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours.
Br J Cancer
; 119(12): 1471-1476, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30425349
3.
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.
Br J Cancer
; 117(9): 1258-1268, 2017 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28859059
4.
Pharmacokinetic study of aldoxorubicin in patients with solid tumors.
Invest New Drugs
; 33(2): 341-8, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25388939
5.
Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors.
Int J Clin Pharmacol Ther
; 53(7): 563-72, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26073352
6.
Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.
Invest New Drugs
; 32(6): 1236-45, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25117475
7.
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
NPJ Precis Oncol
; 7(1): 18, 2023 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36797347
8.
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.
J Cell Mol Med
; 14(10): 2448-59, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19583815
9.
A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma.
Clin Cancer Res
; 26(12): 2819-2826, 2020 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31900279
10.
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Clin Cancer Res
; 14(16): 5000-5, 2008 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18698017
11.
Targeting the mTOR pathway using deforolimus in cancer therapy.
Future Oncol
; 5(3): 291-303, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19374536
12.
PARP Inhibition in Cancer: An Update on Clinical Development.
Target Oncol
; 14(6): 657-679, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31625002
13.
Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
Clin Cancer Res
; 13(11): 3293-301, 2007 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17545535
14.
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.
Cancers (Basel)
; 10(6)2018 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29799479
15.
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Cancer Chemother Pharmacol
; 59(2): 165-74, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16736151
16.
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.
Clin Cancer Res
; 12(24): 7406-13, 2006 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17189413
17.
Statins and pancreatic cancer.
Oncol Lett
; 13(3): 1035-1040, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28454210
18.
Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.
Oncotarget
; 8(49): 86769-86783, 2017 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-29156834
19.
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity.
World J Methodol
; 6(1): 25-42, 2016 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27019795
20.
Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors.
Target Oncol
; 11(6): 807-814, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27457707